Cancer stem cells: Regulation programs, immunological properties and immunotherapy

Area of Science:

• Oncology
• Immunology
• Cancer Stem Cell Biology

Background:

• Most human cancers contain cancer stem cells (CSCs) that resist conventional therapies.
• CSCs are implicated in tumor recurrence, metastasis, and treatment failure.
• Immunotherapy is a crucial cancer treatment, but CSCs remain a challenge.

Purpose of the Study:

• To review CSC regulation and immunological profiling.
• To identify immunogenic CSC antigens for targeted immunotherapy.
• To explore novel immunologic strategies against CSCs in solid tumors.

Main Methods:

• Review of existing literature on CSC regulation.
• Analysis of transcriptomics-based immunological profiling data for CSCs.
• Identification and discussion of potential CSC-specific antigens.

Main Results:

• CSCs possess distinct regulatory programs and immunological characteristics.
• Specific CSC antigens with immunogenic potential have been identified.
• Transcriptomics data offers insights into CSC immune evasion and targeting.

Conclusions:

• Targeting CSCs immunologically holds promise for overcoming therapy resistance.
• Novel immunotherapies could prevent tumor recurrence and eliminate residual disease.
• Further research into CSC immunology is vital for advancing cancer treatment.